{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=AACE%20Pharmaceuticals%2C%20Inc.","name":"AACE Pharmaceuticals, Inc.","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-04T12:53:16.015Z"},"count":1,"matches":[{"id":"4e846fddc612e8bc","posted_date":"2025-05-27","letter_issue_date":"2025-05-13","company_name":"AACE Pharmaceuticals, Inc.","issuing_office":"Center for Drug Evaluation and Research (CDER)","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/4e846fddc612e8bc"}]}